Texarkana Gazette

U.S. vaccinatio­ns ramp up as COVID-19 spurts

- By Matthew Perrone, Lauran Neergaard and David Porter

WASHINGTON — Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccinatio­n drive Tuesday, while a second vaccine moved to the cusp of government authorizat­ion.

A day after the rollout of Pfizer-BioNTech’s coronaviru­s shots, the Food and Drug Administra­tion said its preliminar­y analysis confirmed the effectiven­ess and safety of the vaccine developed by Moderna and the National Institutes of Health. A panel of outside experts is expected to recommend the formula on Thursday, with the FDA’s green light coming soon thereafter.

The Moderna vaccine uses the same technology as Pfizer-BioNTech’s and showed similarly strong protection against COVID-19 but is easier to handle because it does not need to be kept in the deep freeze at minus 94 degrees.

Another weapon against the outbreak can’t come soon enough: The number of dead in the U.S. passed a staggering 300,000 on Monday, according to Johns Hopkins University, with about 2,400 people now dying per day on average.

The devastatin­g toll is only expected to grow in the coming weeks, fueled by travel over Christmas and New Year’s, family gatherings and lax adherence to mask-wearing and other precaution­s.

Packed in dry ice, shipments of the Pfizer-BioNTech vaccine began arriving Tuesday at more than 400 additional hospitals and other distributi­on sites.

The first 3 million shots are being strictly rationed to front-line health workers and nursing home patients, with hundreds of millions more shots needed .

The rollout provided a measure of encouragem­ent to exhausted doctors, nurses and other hospital staffers around the country.

Maritza Beniquez has had a front-row seat to the devastatio­n the COVID-19 pandemic has wrought on communitie­s of color in New Jersey, so she jumped at the chance to take the vaccine that is being hailed as a turning point in the battle against the virus.

The 56-year-old emergency room nurse at Newark’s University Hospital became the first person in New Jersey to receive the vaccine on Tuesday. All recipients will get a second shot a few weeks later.

“I’m happy that in another month and a half I won’t have to be afraid to go into a room anymore. I won’t have to be afraid to perform chest compressio­ns or be present when they’re intubating a patient,” Beniquez said. “I don’t want to be afraid anymore, and I don’t want to have that risk of taking it home to my own family and my own friends.”

Widespread acceptance of the vaccine is critical to eventually protecting enough of the U.S. population to defeat the outbreak. But just half of Americans say they want to get vaccinated, while about a quarter don’t and the rest are unsure, according to a recent poll by The Associated PressNORC Center for Public Health Research.

In Manchester, New Hampshire, intensive care unit nurse Heidi Kukla said she volunteere­d to get the shot first to help dispel fears about the vaccine’s long-term effects and the speed with which it was developed.

“I know a lot of people have reservatio­ns about getting the vaccine,” she said after getting vaccinated at Elliot Hospital. “But I can assure you that there is absolutely nothing worse than being a patient on a ventilator in an ICU anywhere in this country right now with COVID.”

 ?? Associated Press ?? ■ Dr. Margaret Coates reacts after receiving the Pfizer-BioNTech COVID-19 vaccine at the University of Texas Health Austin Dell Medical School on Tuesday in Austin.
Associated Press ■ Dr. Margaret Coates reacts after receiving the Pfizer-BioNTech COVID-19 vaccine at the University of Texas Health Austin Dell Medical School on Tuesday in Austin.

Newspapers in English

Newspapers from United States